Cantitate/Preț
Produs

Genetic Mechanisms in Multiple Endocrine Neoplasia Type 2: Medical Intelligence Unit

Editat de Barry D. Nelkin
en Limba Engleză Paperback – 13 noi 2013
This book examines what is known about the molecular biology of multiple endocrine neoplasia, type 2 (MEN2). Mutations and alterations in gene expressions and signal transduction are placed in the context of their effects on the biology of the thyroid and adrenal cells which generate cancers in MEN2. Thus, this volume addresses the ret mutations, the effects these mutations may have on signal transduction, and developmental and neurobiological aspects of the cells affected of MEN2, and provides the basic researcher - in genetics, signal transduction, cell transformation, developmental or neurobiology - with a better understanding of how the knowledge generated by each of these fields intercalates within the overall biology of MEN2.
Citește tot Restrânge

Din seria Medical Intelligence Unit

Preț: 35383 lei

Preț vechi: 37246 lei
-5% Nou

Puncte Express: 531

Preț estimativ în valută:
6771 7161$ 5648£

Carte tipărită la comandă

Livrare economică 30 decembrie 24 - 13 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783662219508
ISBN-10: 3662219506
Pagini: 220
Ilustrații: XI, 201 p. 33 illus.
Dimensiuni: 178 x 254 x 12 mm
Greutate: 0.39 kg
Ediția:Softcover reprint of the original 1st ed. 1996
Editura: Springer Berlin, Heidelberg
Colecția Springer
Seria Medical Intelligence Unit

Locul publicării:Berlin, Heidelberg, Germany

Public țintă

Research

Cuprins

1. Clinical Manifestations of Multiple Endocrine Neoplasia Type 2.- 2. Mutations in Ret in MEN 2.- 3. Intracellular Signaling by the Ret Tyrosine Kinase.- 4. Mechanisms of Growth Factor-Mediated Signal Transduction in PC12 Cells.- 5. Origin of Adrenal Chromaffin Cells from the Neural Crest.- 6. The Adrenal Medulla in MEN 2.- 7. Neuronal Properties of Thyroid C-Cell Tumor Lines.- 8. Progression of Medullary Thyroid Carcinoma.- 9. Molecular Events in the Development and Progression of Medullary Thyroid Cancer and Pheochromocytoma.- 10. Conclusion.